Seward moves to new premises

Published: 3-Feb-2011
Manufacturing Active Nutrition Food

Doubles manufacturing and storage facilities

Seward Ltd, the manufacturer and developer of the Stomacher laboratory paddle blender range, has moved to new premises in Worthing, UK, which will double the firm’s manufacturing and storage facilities.

The new building represents a significant investment by the company following the securing of a NatWest/RBS Manufacturing Fund. It will also ensure shorter lead times for the Stomacher sample preparation products for microbiological analyses and tissue processing, the company said.

The premises also house a purpose-built r&d laboratory for product development, application assessment and customer protocol development.

Further investment in web conferencing facilities will also allow training webinars and in-depth technical support to be offered to customers, wherever they are located.

The new premises support a much-needed increase in production capacity, driven by new applications and the opening of Seward Inc in Long Island, New York, US in 2009.

In the first half of 2010, sales of the Stomacher laboratory blenders grew by nearly 20%, compared with the same period in 2009. Sales of the Stomacher 80 biomaster range for small tissue processing increased by 53%, while the large volume Stomacher 3500 saw a 72% growth.

‘We are dedicated to maintaining excellence in our products, customer service and support for our rapidly growing global customer base, so the increased size and capacity of our new premises ensures we can guarantee this now and in the future,’ said Stuart Ray, technical director, Seward Ltd.

He added that the firm had also seen strong growth in the US and Asia/Pacific regions.

See more

You may also like

Manufacturing

Seward simplifies cell preparation

Read more
Enhances applications for Strainer bags to include sterile processing of tissue samples

Trending Articles

  1. You need to be a subscriber to read this article.
    Click here to find out more.
    Moving with speed and scale: innovative, material-sparing approaches to accelerate clinical development As early-stage drug development is often hindered by limited API supply, rising costs and tight timelines, material-sparing technologies are helping companies to progress faster with less
  2. Why weight sorting should move earlier in OSD development Phillip Ruda explains how earlier weight intelligence can improve process understanding, reduce risk and accelerate learning cycles
  3. Lyocontract invests €50m in new freeze-drying facility with Syntegon vial line German CDMO Lyocontract has begun construction of a €50m expansion in Ilsenburg, partnering with Syntegon to install a complete vial filling and lyophilisation line for sterile freeze-dried pharmaceuticals
  4. You need to be a subscriber to read this article.
    Click here to find out more.
    The evolution of the CDMO model in Central Europe: strategic partnerships as a catalyst for change As the Central European outsourcing market matures, companies such as Mabion are redefining the CDMO paradigm with integrated biologics expertise and long-term codevelopment partnerships that elevate the region from cost-efficient manufacturer to strategic biopharma collaborator
  5. Chiesi and Bespak expand partnership to boost Carbon Minimal Inhaler production with UK manufacturing site The pair will increase in pressurised metered dose inhaler (pMDI) manufacturing capacity in the UK at Bespak's Holmes Chapel site

Upcoming event

DCAT Week

23–26 March 2026 | Conference | New York, US See all

You may also like

Manufacturing

Seward simplifies cell preparation

Enhances applications for Strainer bags to include sterile processing of tissue samples
Manufacturing

Clariant opens first US pharmaceutical-grade PEG excipient manufacturing site in Texas

Clariant has expanded its Clear Lake facility in Texas to produce GMP-compliant pharmaceutical-grade polyethylene glycol excipients, marking its first US-based manufacturing site for the products and strengthening supply chain resilience for North American and Latin American pharma customers
Design & Build

ESTEVE CDMO expands spray drying and high-potency containment capacity at Girona facility

ESTEVE CDMO has announced plans to add a 3000-square-metre production unit at its Celrà site in Spain to house additional spray drying equipment and high-potency containment suites, with the first new GEA spray dryer due online in Q1 2027
Manufacturing

Abzena named a leader in Frost & Sullivan ADC CDMO radar report

Recognition highlights integrated capabilities, proprietary technology and expertise in antibody-drug conjugates
Manufacturing

LabVantage Solutions introduces LabVantage CORTEX, advancing its LIMS platform for AI-driven laboratory operations

Next-Generation Platform Extends LIMS with Agentic AI and Cloud-Native Automation to Improve Efficiency, Reduce Errors and Gain Deeper Insight from Data. Learn More from LabVantage Leadership at Pittcon 2026
Manufacturing

Schütz to build automated IBC production facility at BASF's Ludwigshafen headquarters

Packaging specialist Schütz has signed an agreement with BASF to construct a highly automated intermediate bulk container manufacturing and storage facility directly adjacent to the chemical giant's main plant in Ludwigshafen, enabling round-the-clock just-in-time delivery
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

LGM Pharma announces $9 million investment into Colorado and Texas manufacturing facilities

The investment marks the second phase of the the company's expansion, funding facility upgrades to increase capacity for suppository, semi-solid and oral solid dose and differentiating LGM in the US CDMO market, says CEO Prasad Raje, speaking exclusively to Manufacturing Chemist
Subscribe now